We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Multiplex PCR Developed for Neglected Infectious Diseases

By LabMedica International staff writers
Posted on 01 Aug 2019
Scrub typhus, murine typhus, and leptospirosis are diagnosed as acute undifferentiated febrile illness. More...
Diagnostic tests for these diseases depend on antibody detection. However, antibody detection is still limited by its tendency to return negative results during the early phase of these diseases.

Early clinical manifestations of scrub typhus, murine typhus, and leptospirosis, such as high fever, headache, muscular pain, and anorexia, are non-specific and usually diagnosed as acute undifferentiated febrile illness. These clinical manifestations range from mild, severe, to possibly fatal.

Scientists at the Chulalongkorn University (Bangkok, Thailand) and their colleagues used 83 EDTA blood samples taken from patients presented with acute undifferentiated febrile illness at various institutions. Patients included were over 18 years old, having acute fever (38 °C or higher), exhibiting non-specific symptoms, (headache, muscular pain, anorexia, and rash for 3–5 days), and tested negative for both influenza and dengue antigens.

The team developed a multiplex polymerase chain reaction PCR to combine three primer pairs that target specific genes encoding 56-kDa TSA of Orientia tsutsugamushi, 17-kDa antigen of Rickettsia typhi, and LipL32 of Leptospira interrogans and evaluate its performance in comparison to the standard serological tests. Multiplex PCR amplification was performed on a Thermal Cycler. Specificity of the multiplex PCR was tested with unrelated pathogens.

Multiplex PCR results were positive in 39 samples (47%), consisting of 22 samples of scrub typhus (26.5%), 11 samples of leptospirosis (13.25%), five samples of murine typhus (6.02%), and one sample of co-infection between scrub typhus and leptospirosis (1.2%). Twenty samples were detected by both serological methods and multiplex PCR. Nineteen samples were detected only by multiplex PCR but tested negative by standard serological methods. The diagnostic sensitivity and specificity of multiplex PCR were 100% and 70%, respectively, when serological methods were used as gold standard. Positive predictive value and negative predictive value of this assay were 51% and 100%, respectively.

The authors concluded that they had developed a novel multiplex PCR assay for identifying causative agents of scrub typhus, murine typhus, and leptospirosis in blood samples. This method is a rapid, sensitive, and specific diagnostic test. The multiplex PCR assay will become useful for the development of better health care and treatment of patients presented with acute undifferentiated febrile illness, particularly in endemic areas of these diseases. The study was published on July 8, 2019, in the journal PLOS Neglected Tropical Diseases.

Related Links:
Chulalongkorn University


Gold Member
Aspiration System
VACUSAFE
Online QC Software
Acusera 24•7
Immunofluorescence Analyzer
IFA System
HPV Test
Allplex HPV28 Detection
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Illustration of the new blood test, which uses a DNA chip to detect the tumor’s biological fingerprint (Photo courtesy of Tel Aviv University)

Blood Test on a Chip Offers Low-Cost Lung Cancer Detection Without DNA Sequencing

Lung cancer is the leading cause of cancer deaths worldwide, and screening often yields indeterminate results that prompt invasive workups. Computed tomography (CT) detects small nodules but can flag benign... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Whole-Cell Genomic Analysis Expands the Potential of Liquid Biopsy

Liquid biopsy has expanded access to tumor genomics, but most blood-based assays rely on short, degraded fragments of cell-free circulating tumor DNA (ctDNA). Isolating intact circulating tumor cells from... Read more

Pathology

view channel
Image: Through the PCCP, Proscia gains a more efficient pathway to expand Concentriq AP-Dx interoperability while maintaining regulatory oversight (Photo courtesy of Proscia)

FDA-Cleared Digital Pathology Platform Expands Interoperability for Primary Diagnosis

Rising cancer incidence is colliding with a shrinking pathologist workforce, intensifying pressure on diagnostic turnaround times in clinical laboratories. Many labs are adopting digital pathology to manage... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.